Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04868292
Status:
COMPLETED
Last Update Posted:
2021-11-17
First Post:
2021-04-13
Brief Title:
Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers
Sponsor:
Spero Therapeutics
Organization:
Spero Therapeutics
Study Overview
Official Title:
A Phase 1 Single-Center Open-Label Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 by Comparing the Plasma Epithelial Lining Fluid and Alveolar Macrophage Concentrations Following the Intravenous Administration of SPR206 in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2021-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the intrapulmonary pharmacokinetics PK including epithelial lining fluid ELF and alveolar macrophage AM concentrations of SPR206 as well as plasma concentrations of SPR206 in healthy adult volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CDMRP-JW180095-A | OTHER_GRANT | None | None |
| 2020-006019-52 | EUDRACT_NUMBER | United States Department of Defense | None |